A tighter archive for life-science signals.
Search once, then narrow by source or topic.
#ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins
Late-breaking abstracts from the annual American Society of Hematology meeting are early this year, coming right before Thanksgiving instead of the previously planned d...
Teva loses IRA drug pricing challenge in DC federal court
Teva’s challenge against Medicare negotiations fell flat in DC federal court, marking another loss for the pharma industry. US District Judge Sparkle Sooknanan said Thu...
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
Plus, news about Blue Lake, Bambusa, Inhibikase Therapeutics and Olema Oncology: 🛑 Sarepta terminates Elevidys trial with Hansa Biopharma’s imlifidase: The study was e...
Lilly becomes first $1 trillion pharma company
Eli Lilly's market valuation briefly reached more than a trillion dollars on Friday, making it the first-ever drugmaker to reach that benchmark. It hit the 13-digit val...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page